Pricing Log in Create free account
Saturday 17 October 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.95 0.76 +0.52%
Market cap
$358.2B
P/E
117×
Fwd P/E
53.9×
Dividend yield
2.33%
F-score
4/9
Altman Z
3.77
Beneish M
−2.27
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Merck & Co., Inc. (MRK) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Merck & Co., Inc. (MRK) trades at a P/S ratio of 5.4×. Over the past ten years it has ranged from 2.9× (May 2025) to 5.8× (August 2026); the current reading is higher than 97% of that period. That is above the Drug Manufacturers General industry median of 3.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 4.1× 3.20%
FY2024 3.9× (17.86%)
FY2023 4.8× 0.68%
FY2022 4.7× 19.23%
FY2021 4.0× (16.29%)
FY2020 4.8× (16.41%)
FY2019 5.7× 23.90%
FY2018 4.6× 25.80%
FY2017 3.7× (8.47%)
FY2016 4.0× 11.00%

Quarterly newest first

Period P/S ratio Change
Jun 2026 4.8× 5.45%
Mar 2026 4.5× 11.61%
Dec 2025 4.1× 24.26%
Sep 2025 3.3× 4.38%
42 more quarters

Against its own ten years

Low 2.9× High 5.8×
Ten-year median 4.3×
Current reading's percentile 97

P/S ratio against peers

Company P/S ratio
PFE Pfizer Inc. compare 2.6×
NVO Novo Nordisk A/S compare 3.3×
AZN AstraZeneca PLC compare 4.2×
NVS Novartis AG compare 5.1×
MRK Merck & Co., Inc. 5.4×
AMGN Amgen Inc. compare 6.1×
JNJ Johnson & Johnson compare 6.2×
GILD Gilead Sciences, Inc. compare 6.4×
ABBV AbbVie Inc. compare 7.8×
Drug Manufacturers General industry median 3.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MRK